Vinva Investment Management Ltd increased its position in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 10.2% during the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 84,704 shares of the company’s stock after purchasing an additional 7,836 shares during the period. Vinva Investment Management Ltd’s holdings in Colgate-Palmolive were worth $8,780,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Gordian Advisors LLC bought a new stake in Colgate-Palmolive during the 3rd quarter valued at $602,000. Carrera Capital Advisors grew its position in shares of Colgate-Palmolive by 23.1% in the 3rd quarter. Carrera Capital Advisors now owns 39,170 shares of the company’s stock worth $4,066,000 after buying an additional 7,353 shares during the last quarter. Vontobel Holding Ltd. lifted its position in Colgate-Palmolive by 224.6% during the third quarter. Vontobel Holding Ltd. now owns 795,938 shares of the company’s stock valued at $82,626,000 after acquiring an additional 550,750 shares during the last quarter. PGGM Investments lifted its position in Colgate-Palmolive by 171.8% during the second quarter. PGGM Investments now owns 157,608 shares of the company’s stock valued at $15,294,000 after acquiring an additional 99,624 shares during the last quarter. Finally, QRG Capital Management Inc. grew its holdings in Colgate-Palmolive by 11.2% in the second quarter. QRG Capital Management Inc. now owns 57,275 shares of the company’s stock worth $5,558,000 after purchasing an additional 5,751 shares during the last quarter. 80.41% of the stock is currently owned by institutional investors.
Colgate-Palmolive Stock Up 0.2 %
CL opened at $96.75 on Thursday. The company has a fifty day moving average of $97.61 and a two-hundred day moving average of $98.58. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a fifty-two week low of $75.50 and a fifty-two week high of $109.30. The stock has a market capitalization of $79.05 billion, a price-to-earnings ratio of 27.72, a PEG ratio of 3.40 and a beta of 0.42.
Colgate-Palmolive Announces Dividend
Analyst Ratings Changes
A number of equities research analysts have commented on the company. Stifel Nicolaus cut Colgate-Palmolive from a “buy” rating to a “hold” rating and decreased their price target for the company from $105.00 to $101.00 in a research note on Monday, October 28th. Redburn Atlantic upgraded shares of Colgate-Palmolive to a “hold” rating in a research note on Thursday, August 1st. UBS Group upped their price target on shares of Colgate-Palmolive from $119.00 to $122.00 and gave the company a “buy” rating in a research note on Wednesday, September 4th. Deutsche Bank Aktiengesellschaft downgraded shares of Colgate-Palmolive from a “buy” rating to a “hold” rating and lifted their price objective for the stock from $107.00 to $109.00 in a research note on Monday, September 9th. Finally, Piper Sandler initiated coverage on Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price on the stock. One analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have given a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $105.11.
Get Our Latest Report on Colgate-Palmolive
Insider Buying and Selling at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the transaction, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. This trade represents a 55.29 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 0.37% of the stock is owned by corporate insiders.
About Colgate-Palmolive
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
See Also
- Five stocks we like better than Colgate-Palmolive
- 3 Healthcare Dividend Stocks to Buy
- Eli Lilly, Pfizer, and AstraZeneca: 2025 Vaccine Makers to Watch
- What Do S&P 500 Stocks Tell Investors About the Market?
- DICK’S Sporting Goods: The Under-the-Radar Buy-and-Hold Winner
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 2 Cheap Quantum Computing Stocks to Buy Instead of Chasing IonQ
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.